A new non-viral vector for gene-therapy in rheumatic diseases.docVIP

Available online /supplements/4/S1 Meeting abstracts 22nd European Workshop for Rheumatology Research Leiden, The Netherlands 28 February – 3 March 2002 Received: 15 January 2002 Published: 4 February 2002 Arthritis Res 2002, 4 (suppl 1) ? 2002 BioMed Central Ltd (Print ISSN 1465-9905; Online ISSN 1465-9913) Aetiopathogenesis of rheumatic diseases 1 logic effects of VEGF in SSc patients. Serum levels of VEGF were also correlated significantly with disease severity parameters including antitopoisomerase antibodies. These results suggest that therapeutic application of VEGF by